PREVIEW: Danaher Corp (DHR) earnings due 27/Jan at 11:00BST/06:00EDT
Danaher Corp (DHR) Q4 2021 (USD): EPS (exp. 2.54/2.13 GAAP), Revenue (exp. 7.92bln)
REVENUE SEGMENTS:
- Diagnostics: (exp. 2.66bln)
- Environmental And Applied Solutions: (exp. 1.23bln)
- Life Sciences: (exp. 3.95bln)
DIVIDEND:
- Qtrly Dividend: (exp. 0.20)
- FY Dividend: (exp. 0.82)
EPS GUIDANCE:
- Q1 2021 EPS View: (exp. 2.49/2.18 GAAP)
- FY 2021 EPS View: (exp. 9.88/8.43 GAAP)
REVENUE GUIDANCE:
- Q1 2021 Revenue View: (exp. 7.42bln)
- FY 2021 Revenue View: (exp. 29.11bln)
- FY 2022 Revenue View: (exp. 30.94bln)
INDEX WEIGHT:
- 0.5% SPX weight
- Sector/Industry: Health Care/Life Sciences Tools & Services
BROKER RATING:
- Avg Rating: 'Buy'
- Avg Price Target: USD 351.08
- Price Target Changes (last 30 days): 6 upward vs 1 downward
26 Jan 2022 - 17:00- - Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts